A pandemic of the Chinese communist virus (Neocoronavirus) is continuing to have vaccine side effects as countries race to get vaccinated. The U.S. federal health agency recommended Tuesday (April 13) that the Johnson & Johnson vaccine be suspended because several subjects developed a rare disease associated with blood clots. The White House later said the change would not affect the federal vaccination program.
The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) issued a joint statement Tuesday recommending a moratorium on the launch of Johnson & Johnson’s single-dose COVID-19 (Chinese Communist Virus-Induced Disease) vaccine. The reason is that six of the vaccine recipients developed severe blood clot symptoms.
The New York Times, citing officials, reported that the six recipients were all women between the ages of 18 and 48. One of the women died and a second from Nebraska has been hospitalized in critical condition.
“At this time, these adverse events appear to be extremely rare.” The FDA tweeted, “Treatment for this specific type of clot is different from what might normally be taken. the CDC will convene an Advisory Committee on Immunization Practices (ACIP) meeting on Wednesday to further review these cases and assess their potential significance. the FDA will also review this analysis as it investigates these cases. “
As of April 12, more than 6.8 million doses of Johnson & Johnson vaccine had been administered in the United States.
However, until the review is complete, the FDA “recommends suspending (vaccination)” of the vaccine to ensure that healthcare providers are aware of the potential for these adverse events and respond to them.
Johnson & Johnson shares fell 3 percent before Tuesday’s opening bell.
Fox News has asked Johnson & Johnson to comment on the federal health agency’s recommendation.
The company had told the White House that it would provide 100 million doses of the vaccine by the end of May, but recently had production problems at its Baltimore plant. And, last week, there were several incidents of adverse reactions among its vaccine recipients, and several vaccination sites closed early as a result.
In Georgia, eight people experienced dizziness. However, officials did not rule out hot weather; in North Carolina, four people were taken to the hospital with “symptoms consistent with known common side effects”; in Iowa, three people experienced extreme dizziness; and in Colorado, 11 people experienced dizziness and nausea.
And less than a week before that, the European drug regulator said four people in the U.S. had developed rare blood clot symptoms after vaccination, which the agency is reviewing.
The FDA plans to hold a news conference at 10 a.m. Tuesday.
White House: Suspension of Johnson & Johnson Vaccination Won’t Affect Federal Programs
The White House and senior health officials said Tuesday that suspending Johnson & Johnson’s single-dose vaccine will not have a lasting or significant impact on the federal government’s vaccination program.
Acting FDA Commissioner Woodcock said in an online news release that she believes the Johnson & Johnson vaccine ban will last only a few days; Jeff Zients, President Joe Biden’s outbreak response coordinator, said in a statement that “this announcement will not have a significant impact on our vaccination program impact.”
Zients added, “To date, Johnson & Johnson vaccines account for less than 5 percent of recorded arm vaccinations in the United States.”
“Under actions taken by the president earlier this year, the United States has secured sufficient doses of Pfizer and Moderna for 300 million of our own people.” He said.
“Over the past few weeks, we have delivered more than 25 million doses of Pfizer and Moderna each week. in fact, this week we will deliver an additional 28 million doses of these vaccines. That’s more than enough supply to continue the current rate of 3 million doses per day of vaccinations.” Ziente added.
Recent Comments